Kayleigh McEnany slams media’s ‘apoplectic’ reaction to Trump taking hydroxychloroquine

Get the latest BPR news delivered free to your inbox daily. SIGN UP HERE.

White House press secretary Kayleigh McEnany made an appearance Tuesday on “Fox & Friends” and slammed the media for its “apoplectic” reporting on President Donald Trump announcing he is taking hydroxychloroquine to ward off COVID-19.

The president told reporters Monday that he has been taking the anti-malaria drug for about a week and a half, and the media world imploded — even on Fox News, as host Neil Cavuto did his best Shepard Smith impersonation, warning everyone that they’re going to die.

McEnany was asked why Trump decided to talk about taking hydroxychloroquine.

“The President just wanted to be transparent about his personal health decision that he made in consultation with his doctor,” she said. “And one of the things that I really want to get out there this morning that unfortunately there’s a lot of misinformation about is — first let me emphasize strongly that any use of Hydroxychloroquine has to be in consultation with your doctor, you have to have a prescription. That’s the way it must be done.”

McEnany noted that she talked to Dr. Stephen Hahn, the head of the Food and Drug Administration, and he told her that hydroxychloroquine has been approved for three other uses.

“We have a lot of information about the safety of this drug, though ultimately you make that decision with your doctor,” she said. “So some of the misreporting on other networks, these apoplectic analyses of hydroxychloroquine ignore the fact that tens of millions of people around the world have used this drug for other purposes, including some people in my communications office who used it for malaria prophylaxis before traveling to other parts of the world.”

Fox News host Steve Doocy inquired about what may have prompted Trump to start taking the drug.

“Did the President start taking it 10 days ago because a couple of the members of the White House staff tested positive and suddenly the coronavirus was inside the West Wing complex and he was just worried about that?” he asked. “Is that why he started or had he been talking with his doctor about taking it for a while?”

“I don’t have any information about the exact rationale,” McEnany said. “That was a personal deliberation with [White House physician Dr. Sean Conley] and the president. But as has been noted, the president has said pretty widely this is a drug that he has looked at with optimism.”

“But nevertheless, he said that this is a decision that must be made with the doctor — as he’s repeatedly said,” she concluded.

President Trump expressed his displeasure with Fox News late Monday, responding to a tweet about Cavuto’s reaction to his announcement.

“[Fox News] is no longer the same. We miss the great Roger Ailes. You have more anti-Trump people, by far, than ever before. Looking for a new outlet!” the president said.

With so much of the media panning hydroxychloroquine, a survey of more than 6,200 doctors in 30 countries conducted by the global health care polling company Sermo, found that 37% of those treating patients with the coronavirus rated the anti-malarial drug as the “most effective therapy,” according to the Daily Wire.


Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

Success! Thank you for donating. Please share BPR content to help combat the lies.
Tom Tillison


We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.

PLEASE JOIN OUR NEW COMMENT SYSTEM! We love hearing from our readers and invite you to join us for feedback and great conversation. If you've commented with us before, we'll need you to re-input your email address for this. The public will not see it and we do not share it.

Latest Articles